Legal status · Canada
Is Empagliflozin legal in Canada?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
Yes. Empagliflozin is an approved medicine in Canada, classified as "Health Canada approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 4 human studies are cited on its profile.
Empagliflozin in Canada at a glance
| Classification | Health Canada approved, prescription only |
|---|---|
| Health Canada approval status | Approved by Health Canada for its labeled use |
| Human studies cited | 4 of 6 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Empagliflozin profile, checked against Health Canada, Health Products and Food Branch (Health Canada) listings at the reviewed date.
What this means
- 01
Health Canada has approved Empagliflozin for at least one labeled indication, so a pharmaceutical-grade product exists in Canada and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Empagliflozin is
Four randomised outcome trials in more than 23,000 people, including a 32 percent relative reduction in all-cause death in EMPA-REG OUTCOME. The entire ageing case is one single-laboratory mouse study reporting 5.9 percent longer median survival in males, and the Interventions Testing Program has never tested this drug.
Empagliflozin blocks the kidney transporter that reabsorbs filtered glucose, so glucose and the sodium travelling with it leave in the urine. It was licensed as a diabetes drug and then turned out to do something its mechanism did not obviously predict, which is reduce cardiovascular death, heart failure hospitalisation and kidney disease progression, including in people without diabetes.
Mechanism: Selectively inhibits sodium-glucose cotransporter 2 in the proximal tubule, so filtered glucose is excreted rather than reabsorbed. The cardiorenal benefit is larger and faster than glucose lowering alone explains and is not fully accounted for.
Regulatory history: FDA approved for type 2 diabetes, for reducing cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, for heart failure across the ejection fraction range, and for chronic kidney disease. Not approved for ageing, longevity or healthspan.
How Health Canada treats this kind of product
Authorises drugs for sale through a Notice of Compliance and Drug Identification Number. A compound that is not authorised for sale cannot lawfully be sold for human use, and personal importation of prescription drugs is limited.
The classification above is the The Longevity Archive reading of Health Canada, Health Products and Food Branch listings for Empagliflozin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Empagliflozin in other countries
Frequently asked questions
Is Empagliflozin legal in Canada?
Yes. Empagliflozin is an approved medicine in Canada, classified as "Health Canada approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. On the evidence, 4 human studies are cited on its profile.
Can I buy Empagliflozin in Canada?
Only with a prescription. Empagliflozin is classified as "Health Canada approved, prescription only" in Canada, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Empagliflozin Health Canada approved?
Yes, for its labeled indication. In Canada Empagliflozin is classified as "Health Canada approved, prescription only". For comparison, the US FDA status is: FDA approved for type 2 diabetes, for reducing cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, for heart failure across the ejection fraction range, and for chronic kidney disease. Not approved for ageing, longevity or healthspan.. On the evidence, 4 human studies are cited on its profile.
Related compounds in Canada
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Empagliflozin live on its compound profile.
Empagliflozin profileThis page is general information about the regulatory status of Empagliflozin in Canada, current as of Sep 2026. It is not legal advice, and classifications change; check Health Canada, Health Products and Food Branch directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.